Skip to main content

Dr. David A. Morrow, MD

Cardiology (Cardiovascular Disease Physician)

  • Medicare participating

At a glance

Medical school
Harvard Medical School (1994)
Years since graduation
32
In the NPI registry since
2005
Medicare patients seen, 2024
1,054

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1994Medical school: Harvard Medical School
  • 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Cardiovascular Disease Physician primary
    MA license 152630

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Cardiology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
1,054
Services billed
1,502
Patients’ average age
73
Most frequent Medicare services, 2023
ServiceTimesPatients
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only1,037862
Critical care, first 30-74 minutes14554
Established patient office or other outpatient visit, 30-39 minutes3736
Established patient office or other outpatient visit, 20-29 minutes3129
Established patient office or other outpatient visit, 40-54 minutes3029
Critical care, each additional 30 minutes2413
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes2219
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes1913
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes1111

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 2 companies reported 2 payments worth $2,717 in total to this clinician.

By type
Consulting Fee$2,700
Food and Beverage$17.39

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Dec 8, 2025Novartis Pharmaceuticals Corporation
Dec 8, 2025
Consulting Fee
LEQVIO · Cardiology/Vascular Diseases
$2,700

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Massachusetts →

Industry-funded research

Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $1,163,773 in research payments for these studies, mostly to the institutions running them.

  • A phase 2 doubleblind randomized placebocontrolled 4ARM study to investigate symptoms function healthrelated quality of life and safety with repeated subcutaneous administration of ponsegromab versus placebo in adult …
    Pfizer Inc.
  • A Phase IIB Randomized Double blinded Placebo controlled Parallel group Study to Evaluate the Efficacy and Safety of MEDI6570 in Participants with a Prior Myocardial Infarction Persistent Inflammation and Elevated N t…
    AstraZeneca UK Limited
  • Observational Assessment of Support With Impella Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
    Abiomed

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Cardiology clinicians in Boston

Sources

NPI registry (CMS NPPES, November 2026; record last updated May 1, 2012), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1316928039. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.